FDA Adverse Event Injury Summary report: N

IMPLANTABLE INFUSION PUMP

MDR report key: 5700798 · Received June 6, 2016

Report

Report Number
3007566237-2016-02200
Event Type
Injury
Date Received
June 6, 2016
Date of Event
November 19, 2015
Report Date
June 6, 2016
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IT WAS NOT POSSIBLE TO MATCH THIS EVENT WITH ANY PREVIOUSLY REPORTED EVENT. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

JAMES, L., WUNNAVA, M. UNUSUAL REIMPLANTATION OF BACLOFEN PUMP WITH COMPLICATED WEAN AND WITHDRAWAL: A CASE REPORT. REGIONAL ANESTHESIA AND PAIN MEDICINE. 2016. 41(2). ABSTRACT 798. SUMMARY/REPORTED EVENTS: A (B)(6) FEMALE WITH HISTORY OF SEVERE SYSTEMIC SPASTICITY SECONDARY TO TRAUMATIC BRAIN INJURY DUE TO MOTOR VEHICLE COLLISION AT THE AGE OF (B)(6). THE PATIENT PRESENTED TO OUTPATIENT PAIN MEDICINE CLINIC WITH PREEXISTING INTRATHECAL BACLOFEN PUMP. SHE REQUIRED ROUTINE REVISION OF THE INTRATHECAL DRUG DELIVERY SYSTEM DUE TO MANUFACTURER PROTOCOL AND WAS SET UP FOR REVISION SURGERY. THE PATIENT¿S SURGICAL COURSE WAS COMPLICATED BY POOR POST-OP WOUND HEALING AND DESPITE CONSERVATIVE MEASURES, SHE DEVELOPED POSTOPERATIVE INFECTION REQUIRING ADMISSION TO INPATIENT HOSPITAL FOR INTRAVENOUS ANTIBIOTICS. THE PATIENT UNDERWENT INTRATHECAL BACLOFEN WEAN AND SUBSEQUENT WITHDRAWAL. SHE WAS STARTED ON ORAL BACLOFEN AND DANTROLENE AND THE INTRATHECAL DRUG DELIVERY SYSTEM WAS EXPLANTED BY NEUROSURGERY, BUT SHE CONTINUED TO HAVE SEVERE FUNCTIONAL IMPAIRMENTS DUE TO UNCONTROLLED SPASTICITY. THE INTRATHECAL DRUG DELIVERY SYSTEM WAS REIMPLANTED 35 DAYS AFTER EXPLANTATION WHILE STILL ON INTRAVENOUS ANTIBIOTICS DUE TO HER POOR FUNCTIONAL PERFORMANCE, THAT WAS A BARRIER FOR SELF CARE AND SAFE DISCHARGE. FOLLOWING REIMPLANTATION, THERE WERE NO SURGICAL COMPLICATIONS UPON FOLLOW UP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
355869 IMPLANTABLE INFUSION PUMP PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION NEU_UNKNOWN_PUMP UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 37 YR Hospitalization| R